Home/Turn Therapeutics/Dr. Neil Ghodadra, MD
DN

Dr. Neil Ghodadra, MD

Chief Medical Officer, Board Director

Turn Therapeutics

Turn Therapeutics Pipeline

DrugIndicationPhase
GX-03Eczema (Atopic Dermatitis)Phase 1
Unnamed Onychomycosis ProgramOnychomycosisLate-stage clinical
Hexagen™ Wound DressingWound CareApproved/FDA-cleared
Thermostable Vaccine DeliveryInfectious Disease (Global Health)Not specified